Drug Shortage Report for PRALUENT

Last updated on 2021-05-04 History
Report ID 137220
Drug Identification Number 02453835
Brand name PRALUENT
Common or Proper name Praluent
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) ALIROCUMAB
Strength(s) 150MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 2
ATC code C10AX
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-04-29
Actual start date
Estimated end date 2021-05-14
Actual end date 2021-05-03
Shortage status Resolved
Updated date 2021-05-04
Company comments A manufacturing delay may create a short term shortage. Supplies are expected by early May, shortage should be avoided as allocation will be put in place.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2021-05-04 French Compare
v6 2021-05-04 English Compare
v5 2021-04-30 English Compare
v4 2021-04-09 French Compare
v3 2021-04-09 English Compare
v2 2021-04-09 French Compare
v1 2021-04-09 English Compare